Chronic toxicity study of Sameera Pannaga Rasa in Charle's foster albino rats.

Ayu Pub Date : 2020-01-01 Epub Date: 2021-07-30 DOI:10.4103/ayu.AYU_49_20
Madhvi Sharma, Biswajyoti Patgiri, Mukesh B Nariya, Shrirang Jamadagni, Prashant Bedarkar
{"title":"Chronic toxicity study of <i>Sameera Pannaga Rasa</i> in Charle's foster albino rats.","authors":"Madhvi Sharma,&nbsp;Biswajyoti Patgiri,&nbsp;Mukesh B Nariya,&nbsp;Shrirang Jamadagni,&nbsp;Prashant Bedarkar","doi":"10.4103/ayu.AYU_49_20","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong><i>Sameera</i> <i>Pannaga</i> <i>Rasa</i> (SPR) is a <i>Kupi</i> <i>Pakwa</i> <i>Rasayana</i> (a mercurial-arsenical formulation of <i>Ayurveda</i> prepared by specific pharmaceutical-controlled, indirect heat treatment [sand bath] in glass bottle) that contains <i>Shodhita</i> <i>Parada</i> (processed mercury), <i>Shodhita</i> <i>Gandhaka</i> (processed sulfur), <i>Shodhita</i> <i>Haratala</i> (processed arsenic trisulfide), <i>Shodhita</i> <i>Somala</i> (processed arsenic oxide) and <i>Shodhita</i> <i>Manahshila</i> (process arsenic disulfide) in equal quantity as ingredients. <i>Parada</i>, <i>Haratala</i>, <i>Manahshila</i> and <i>Somala</i> are highly potent minerals which are included in the Drug and Cosmetic Act 1940 under Schedule E1 because of their toxic nature in crude form.</p><p><strong>Materials and methods: </strong>In the present study, SPR was evaluated for safety profile through its chronic toxicity study in Charle's foster albino rats. The test drug was made into suspension in vehicle (4 ml honey and 7 ml distilled water). The test drug was administered orally once a day for 90 consecutive days in the dose of 11.25 (therapeutic dose [TED]), 56.25 (5 times TED) and 112.25 mg/kg (10 times TED). Animals were sacrificed on 91<sup>st</sup> day and animals of recovery group were sacrificed on 121<sup>st</sup> day. Parameters such as hematological, serum biochemical, and histopathology of various organs were studied.</p><p><strong>Results: </strong>Test drug at a higher dose level and recovery study showed no toxic effect in albino rats during chronic toxicity study.</p><p><strong>Conclusion: </strong>SPR is found to have no toxic effect in albino rats during the repeated dose, oral, chronic toxicity study of 90 days, even at 10 times therapeutic equivalent dose (112.25 mg/kg) and even during recovery period of 1 month. It may be safety used at TED level.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/93/AYU-41-36.PMC8415237.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ayu","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ayu.AYU_49_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/7/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: Sameera Pannaga Rasa (SPR) is a Kupi Pakwa Rasayana (a mercurial-arsenical formulation of Ayurveda prepared by specific pharmaceutical-controlled, indirect heat treatment [sand bath] in glass bottle) that contains Shodhita Parada (processed mercury), Shodhita Gandhaka (processed sulfur), Shodhita Haratala (processed arsenic trisulfide), Shodhita Somala (processed arsenic oxide) and Shodhita Manahshila (process arsenic disulfide) in equal quantity as ingredients. Parada, Haratala, Manahshila and Somala are highly potent minerals which are included in the Drug and Cosmetic Act 1940 under Schedule E1 because of their toxic nature in crude form.

Materials and methods: In the present study, SPR was evaluated for safety profile through its chronic toxicity study in Charle's foster albino rats. The test drug was made into suspension in vehicle (4 ml honey and 7 ml distilled water). The test drug was administered orally once a day for 90 consecutive days in the dose of 11.25 (therapeutic dose [TED]), 56.25 (5 times TED) and 112.25 mg/kg (10 times TED). Animals were sacrificed on 91st day and animals of recovery group were sacrificed on 121st day. Parameters such as hematological, serum biochemical, and histopathology of various organs were studied.

Results: Test drug at a higher dose level and recovery study showed no toxic effect in albino rats during chronic toxicity study.

Conclusion: SPR is found to have no toxic effect in albino rats during the repeated dose, oral, chronic toxicity study of 90 days, even at 10 times therapeutic equivalent dose (112.25 mg/kg) and even during recovery period of 1 month. It may be safety used at TED level.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
白化大鼠慢性毒性研究。
简介:Sameera Pannaga Rasa (SPR)是一种Kupi Pakwa Rasayana(一种阿育陀汞砷配方,通过特定的药物控制,间接热处理[砂浴]在玻璃瓶中制备),含有等量的Shodhita Parada(加工汞),Shodhita Gandhaka(加工硫),Shodhita Haratala(加工三硫化砷),Shodhita Somala(加工氧化砷)和Shodhita Manahshila(加工二硫化砷)作为成分。Parada, Haratala, Manahshila和Somala是强效矿物质,由于其原始形式的毒性,被列入1940年药物和化妆品法案附表E1。材料与方法:本研究通过对charles’s寄养的白化大鼠进行慢性毒性研究,评价SPR的安全性。将待试药物用4 ml蜂蜜和7 ml蒸馏水制成悬液。试验药物口服剂量为11.25(治疗剂量[TED])、56.25(5倍TED)和112.25 mg/kg(10倍TED),每天1次,连续90天。第91天处死动物,恢复组第121天处死动物。对各脏器的血液学、血清生化、组织病理学等指标进行了研究。结果:在慢性毒性研究中,高剂量试验药物和恢复研究对白化病大鼠无毒性作用。结论:在90天的重复给药、口服、慢性毒性研究中,即使在10倍治疗当量剂量(112.25 mg/kg)和恢复期1个月时,SPR对白化病大鼠均无毒性作用。在TED上使用可能是安全的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Ayu
Ayu
自引率
0.00%
发文量
0
期刊最新文献
A systematic review in health care: Need and significance. Ayurveda fundamentals and science - A perspective. Management of Mutrashmari (urolithiasis) with Palasha Kshara and Ashmarihara Kwatha: An open-labelled placebo-controlled clinical trial. A lexical review on Vishaghna Dravyas of Kaideva Nighantu. Antioxidant content and activity of stem and leaf extracts of Gouania longipetala Hemsl. (Rhamnaceae).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1